IMMUPHARMA PLC
Ownership & governance
Executives 5Directors 6Avg age 57Avg tenure 4.1y
TM
Tim McCarthy McCarthy
Chief Executive Officer
Age 70Since 2021-07-29Profile →
+10
Executives5
TM
Tim McCarthy McCarthy→
Chief Executive Officer
Age 70Since 2021-07-29
AC
Ashley Clarke→
Director of Finance/CFO
—Since 2024-12-02
LM
Laura Mauran-Ambrosino→
Chief Tech/Sci/R&D Officer
—Since 2025-08-31
SG
Sebastien Goudreau→
Chief Tech/Sci/R&D Officer
Age 45Since 2023-08-10
TF
Timothy Franklin→
Chief Operating Officer
Age 62Since 2020-10-31
Board of directors6
LB
Lisa Baderoon→
Director/Board Member
Age 60Since 2021-07-28
TM
Tim McCarthy McCarthy→
Chairman
Age 70Since 2015-09-29
TF
Timothy Franklin→
Director/Board Member
Age 62Since 2021-07-15
LR
Laurence Reilly→
Director/Board Member
Age 44Since 2023-08-10
SG
Sebastien Goudreau→
Director/Board Member
Age 45Since 2023-08-10
KP
Ketan Ratna Kanji Patel→
Director/Board Member
Age 53Since 2025-10-11
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Lanstead Capital Investors LP | 17.99 % | 112,236,910 |
| KW Investment Management Ltd. | 15.89 % | 99,124,000 |
| IG Markets Ltd. | 6.75 % | 42,112,000 |
| Hargreaves Lansdown Fund Managers Ltd. | 5.368 % | 33,490,000 |
| HSBC Global Asset Management (UK) Ltd. | 5.042 % | 31,457,000 |
Catalog · 2026-07-09
Registry officers11
| Name | Role | Since | Shares |
|---|---|---|---|
| Ashley Clarke | Director of Finance/CFO | 2024-12-02 | - |
| Laura Mauran-Ambrosino | Chief Tech/Sci/R&D Officer | 2025-08-31 | - |
| Sebastien Goudreau | Chief Tech/Sci/R&D Officer | 2023-08-10 | - |
| Tim McCarthy McCarthy | Chief Executive Officer | 2021-07-29 | - |
| Tim McCarthy McCarthy | Chairman | 2015-09-29 | - |
| Timothy Franklin | Chief Operating Officer | 2020-10-31 | - |
| Ketan Ratna Kanji Patel | Director/Board Member | 2025-10-11 | - |
| Laurence Reilly | Director/Board Member | 2023-08-10 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.